Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 2, 2001, Pages 319-324

  Kimura, Hiroshi ^a,b,c,d,e   Okada, Osamu ^a,b,c,d   Tanabe, Nobuhiro ^a,b,c,d   Tanaka, Yoshihiro ^a,b,c,d   Terai, Masaru ^a,b,c,d   Takiguchi, Yuichi ^a,b,c,d   Masuda, Masahisa ^a,b,c,d   Nakajima, Nobuyuki ^a,b,c,d   Hiroshima, Kenzo ^a,b,c,d   Inadera, Hidekuni ^a,b,c,d   Matsushima, Kouji ^a,b,c,d   Kuriyama, Takayuki ^a,b,c,d  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c Japan Self Defense Forces Central Hospital   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD PRESSURE; CELL ACTIVATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG VASCULAR RESISTANCE; MACROPHAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RECEPTOR UPREGULATION; SHEAR STRESS;

EID: 0035880178     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.2.2006154     Document Type: Article

References (35)

1. Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art
2. Vascular remodeling
3. Role of hemodynamics in pulmonary vascular remodeling: Implications for primary pulmonary hypertension
4. Longterm follow-up of patients with pulmonary thromboembolism: Late prognosis and evolution of hemodynamic and respiratory data
5. Long-term outcome after pulmonary thromboendarterectomy
6. Chronic thrombotic obstruction of major pulmonary arteries: Results of thromboendarterectomy in 15 patients
7. Chronic thromboembolic pulmonary hypertension: Clinical picture and surgical treatment
8. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange
9. Long-term outcome after pulmonary thromboendarterectomy
10. Pulmonary hypertension and inflammation
11. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
12. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes
13. Elevated circulating levels of C-C chemokines in patients with congestive heart failure
14. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload
15. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension
16. Chemokine macrophage inflammatory protein-1 alpha mRNA expression in lung biopsy specimens of primary pulmonary hypertension
17. Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: Implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD)
18. Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to a monocyte chemotactic and activating factor/monocyte chemoattractant protein-1
19. Vascular endothelial growth factor in pulmonary hypertension
20. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes
21. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations
22. High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension
23. Lupus anticoagulant, high levels of anticardiolipin, and antibeta 2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension
24. Chronic major-vessel thromboembolic pulmonary artery obstruction: Appearance at angiography
25. Vascular remodeling in primary pulmonary hypertension: Potential role for transforming growth factor-β
26. Regulation of placental monocyte chemotactic and activating factor during pregnancy and chorioamnionitis
27. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium
28. Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells
29. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension
30. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries
31. Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension
32. Inflammation in acute coronary syndromes
33. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure
34. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
35. Tumor necrosis factor alpha (TNFα) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity